Saturday, November 23, 2024

FDA Sources Sought: Advanced Product Characterization and Artificial Intelligence

Notice ID: FDA-SSN-117294

Description

The Division of Product Quality conducts research to advance the adoption of emerging technology for pharmaceutical manufacturing and development of generics of complex drug product. To this end, DPQR is seeking contractual service for non-invasive highresolution imaging and Artificial Intelligence image analysis to characterize freeze-dried pharmaceuticals, and complex drug products to understand the impact of advanced manufacturing techniques, formulation, and process parameters on product quality and performance.

Objectives – To seek a contract service for non-invasive high-resolution image and AI analysis of pharmaceutical products, measure and simulate physical and microstructural parameters, correlate measured and simulated parameters with product performance, and process parameters.

Period of Performance – The period of performance for this IDIQ Contract will be for five (5) years.

Read more here.

[related-post]

LEAVE A REPLY

Please enter your comment!
Please enter your name here

FedHealthIT Xtra – Find Out More!

Recent News

Don’t Miss A Thing

Subscribe to our mailing list

* indicates required